IOVA icon

Iovance Biotherapeutics
IOVA

Overview Fund Activity

217 hedge funds and large institutions have $1.1B invested in Iovance Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 83 increasing their positions, 71 reducing their positions, and 47 closing their positions.

Holders
217
Holders Change
-24
Holders Change %
-9.96%
% of All Funds
3.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
83
Reduced
71
Closed
47
Calls
$9.1M
Puts
$3.82M
Net Calls
+$5.28M
Net Calls Change
-$11.1M

Top Buyers

1
MFM
1
MHR Fund Management
New York
$76.7M
2
State Street
2
State Street
Massachusetts
$94M
3
Morgan Stanley
3
Morgan Stanley
New York
$31.8M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$20.5M
5
Citadel Advisors
5
Citadel Advisors
Florida
$14.7M

Top Sellers

1
PAMS
1
Pictet Asset Management (Switzerland)
Switzerland
$2.81M
2
APM
2
Avidity Partners Management
Texas
$0
3
ACA
3
Avoro Capital Advisors
New York
$44.9M
4
Franklin Resources
4
Franklin Resources
California
$21.1M
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$24K
Name Market Value Shares Shares
Change 		Shares
Change %
State Street
1
State Street
Massachusetts
$94M 14,715,475 +4,783,323 +48%
Vanguard Group
2
Vanguard Group
Pennsylvania
$92.4M 14,463,082 +209,328 +1%
BlackRock
3
BlackRock
New York
$77.2M 12,077,102 +610,610 +5%
MFM
4
MHR Fund Management
New York
$76.7M 11,997,103 +11,997,103 New
PA
5
Perceptive Advisors
New York
$63.7M 9,971,780 -276,844 -3%
ACA
6
Avoro Capital Advisors
New York
$44.9M 7,020,000 -2,000,000 -22%
Morgan Stanley
7
Morgan Stanley
New York
$31.8M 4,969,869 +3,921,869 +374%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$27M 4,221,760 +1,526,540 +57%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$24.6M 3,848,731 -862,583 -18%
Goldman Sachs
10
Goldman Sachs
New York
$23.3M 3,643,065 +648,086 +22%
Franklin Resources
11
Franklin Resources
California
$21.1M 3,299,222 -1,882,924 -36%
Renaissance Technologies
12
Renaissance Technologies
New York
$20.5M 3,200,900 +2,392,300 +296%
Norges Bank
13
Norges Bank
Norway
$19M 2,974,857 +1,578,500 +113%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$17.9M 2,806,381 +134,223 +5%
Artisan Partners
15
Artisan Partners
Wisconsin
$17.5M 2,735,732 -22,841 -0.8%
CS
16
Credit Suisse
Switzerland
$17M 2,665,580 +55,875 +2%
Sumitomo Mitsui Trust Group
17
Sumitomo Mitsui Trust Group
Japan
$16.5M 2,587,618 -111,795 -4%
NAMA
18
Nikko Asset Management Americas
New York
$16.5M 2,587,618 -111,795 -4%
JPMorgan Chase & Co
19
JPMorgan Chase & Co
New York
$14.9M 2,336,120 +222,842 +11%
Citadel Advisors
20
Citadel Advisors
Florida
$14.7M 2,294,042 +1,862,210 +431%
MB
21
MPM BioImpact
Massachusetts
$13.7M 2,149,550 +449,550 +26%
LFCM
22
Long Focus Capital Management
Puerto Rico
$13.2M 2,061,814 +1,125,814 +120%
O
23
OrbiMed
New York
$12.8M 2,007,458 – –
RHJA
24
Rice Hall James & Associates
California
$11.6M 1,822,080 +388,024 +27%
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$10.9M 1,710,842 +267,794 +19%
1
2 3 4 5